New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication

被引:6
作者
Qin, Sha [1 ,2 ]
Xie, Bin [1 ]
Wang, Qingyi [1 ,2 ]
Yang, Rui [1 ,2 ]
Sun, Jingyue [1 ,2 ]
Hu, Chaotao [3 ]
Liu, Shuang [4 ]
Tao, Yongguang [1 ,5 ,6 ]
Xiao, Desheng [1 ,2 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha, Hunan, Peoples R China
[2] Cent South Univ, Sch Basic Med Sci, Xiangya Sch Med, Dept Pathol, Changsha, Hunan, Peoples R China
[3] Univ Chinese Acad Sci, Med Sch, Regenerat Med, Beijing, Peoples R China
[4] China Univ, Cent South Univ, Xiangya Hosp, Dept Oncol,Inst Med Sci,Natl Clin Res Ctr Geriatr, Changsha, Hunan, Peoples R China
[5] Cent South Univ, Canc Res Inst, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China
[6] Cent South Univ, Sch Basic Med, Changsha, Hunan, Peoples R China
来源
MEDCOMM | 2024年 / 5卷 / 06期
基金
中国国家自然科学基金;
关键词
cancer immunotherapy; epigenetic modification; immune cells communication; metabolic modulation; REGULATORY T-CELLS; INFILTRATING LYMPHOCYTE THERAPY; TUMOR-ASSOCIATED MACROPHAGES; FDA APPROVAL; LUNG-CANCER; SUPPRESSOR-CELLS; DENDRITIC CELLS; PROGNOSTIC BIOMARKER; MURINE MODEL; CROSS-TALK;
D O I
10.1002/mco2.551
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cancer is one of the leading causes of death worldwide, and more effective ways of attacking cancer are being sought. Cancer immunotherapy is a new and effective therapeutic method after surgery, radiotherapy, chemotherapy, and targeted therapy. Cancer immunotherapy aims to kill tumor cells by stimulating or rebuilding the body's immune system, with specific efficiency and high safety. However, only few tumor patients respond to immunotherapy and due to the complex and variable characters of cancer immune escape, the behavior and regulatory mechanisms of immune cells need to be deeply explored from more dimensions. Epigenetic modifications, metabolic modulation, and cell-to-cell communication are key factors in immune cell adaptation and response to the complex tumor microenvironment. They collectively determine the state and function of immune cells through modulating gene expression, changing in energy and nutrient demands. In addition, immune cells engage in complex communication networks with other immune components, which are mediated by exosomes, cytokines, and chemokines, and are pivotal in shaping the tumor progression and therapeutic response. Understanding the interactions and combined effects of such multidimensions mechanisms in immune cell modulation is important for revealing the mechanisms of immunotherapy failure and developing new therapeutic targets and strategies. Relationships between immune cell metabolism, epigenetics modulation, and cancer immunotherapy clinical efficiency. Epigenetic regulation (including DNA methylation, RNA methylation, histone modification, and chromatin remodeling) of immune cells can influence the differentiation and activity of immune cells, while metabolic status influences the energy supply and reactivity of immune cells, and they are participated in cancer immunotherapy and influenced clinical effect through immune cells as a bridge. (Me, methylation; U, ubiquitination; Ac, acetylation; P, phosphorylation). image
引用
收藏
页数:32
相关论文
共 299 条
  • [1] Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
    Abramson, Jeremy S.
    Palomba, M. Lia
    Gordon, Leo I.
    Lunning, Matthew A.
    Wang, Michael
    Arnason, Jon
    Mehta, Amitkumar
    Purev, Enkhtsetseg
    Maloney, David G.
    Andreadis, Charalambos
    Sehgal, Alison
    Solomon, Scott R.
    Ghosh, Nilanjan
    Albertson, Tina M.
    Garcia, Jacob
    Kostic, Ana
    Mallaney, Mary
    Ogasawara, Ken
    Newhall, Kathryn
    Kim, Yeonhee
    Li, Daniel
    Siddiqi, Tanya
    [J]. LANCET, 2020, 396 (10254) : 839 - 852
  • [2] Tryptase Regulates the Epigenetic Modification of Core Histones in Mast Cell Leukemia Cells
    Alanazi, Sultan
    Rabelo Melo, Fabio
    Pejler, Gunnar
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [3] Non-coding RNAs, another side of immune regulation during triple-negative breast cancer
    Alghazali, Maha Waleed
    Al-Hetty, Hussein Riyadh Abdul Kareem
    Ali, Zahraa Muhsen M.
    Saleh, Marwan Mahmood
    Suleiman, Ahmed Abdul Jabbar
    Jalil, Abduladheem Turki
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2022, 239
  • [4] Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity
    Anfray, Clement
    Mainini, Francesco
    Digifico, Elisabeth
    Maeda, Akihiro
    Sironi, Marina
    Erreni, Marco
    Anselmo, Achille
    Ummarino, Aldo
    Gandoy, Sara
    Exposito, Francisco
    Redrado, Miriam
    Serrano, Diego
    Calvo, Alfonso
    Martens, Marvin
    Bravo, Susana
    Mantovani, Alberto
    Allavena, Paola
    Andon, Fernando Torres
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (09)
  • [5] Advancing Cancer Therapy
    不详
    [J]. NATURE CANCER, 2021, 2 (03) : 245 - 246
  • [6] Histone Modifications and Cancer
    Audia, James E.
    Campbell, Robert M.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2016, 8 (04):
  • [7] FDA Approval of Tisagenlecleucel Promise and Complexities of a $475 000 Cancer Drug
    Bach, Peter B.
    Giralt, Sergio A.
    Saltz, Leonard B.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (19): : 1861 - 1862
  • [8] Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer
    Bai, Yuezong
    Xie, Tong
    Wang, Zhenghang
    Tong, Shuang
    Zhao, Xiaochen
    Zhao, Feilong
    Cai, Jinping
    Wei, Xiaofan
    Peng, Zhi
    Shen, Lin
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (03)
  • [9] Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy
    Bai, Ziyi
    Zhou, Yao
    Ye, Zifan
    Xiong, Jialong
    Lan, Hongying
    Wang, Feng
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [10] Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors
    Balta, Emre
    Wabnitz, Guido H.
    Samstag, Yvonne
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)